Skip to main content

Antimicrobial activity of cefepime and rifampicin in cerebrospinal fluid in vitro

Objectives

Although antimicrobial agents are used for infections of the central nervous system (CNS), their pharmacodynamics is commonly evaluated only in commercially available bacterial growth media. It has been described that different media such as cerebrospinal fluid (CSF) may affect the activity of antibiotics [1, 2]. Due to documented penetration into CSF, cefepime and rifampicin are used for treatment of CNS infections. In the present study, the effects of CSF on bacterial killing by these agents were investigated.

Methods

CSF was collected from over 150 patients without antibiotic therapy. The samples were pooled, stored at -80° and sterile-filtered before use. Time-kill curves of cefepime and rifampicin were performed over 24 h using drug concentrations of 0.25, 0.5, 1, 2, 4 and 8-fold the respective MIC for the Staphylococcus aureus ATCC 29213 strain. Killing curves were performed in Mueller-Hinton broth (MHB), in CSF incubated in ambient air (CSFair) and in CSF in air with 5% CO2 (CSFCO2). CO2 was used to adjust the pH of CSF to physiological values as previously recommended [3].

Results

Bacterial growth in CSF was slower and less pronounced than in MHB resulting in bacterial counts that were ~10-fold lower in CSF than in MHB after overnight incubation. However, sustained bacterial killing was achieved by cefepime at lower drug concentrations in CSFCO2 than in MHB. In contrast, rifampicin concentrations above the MIC were required to exert sustained killing in CSFCO2. Both drugs were least effective in CSFair due to the increase of the pH to 9–10 which is known to reduce the activity of both agents.

Conclusion

Standard susceptibility tests may lead to over- or underestimation of the activity of distinct antibiotics in CSF. Evaluation of the antimicrobial activity in pH-adjusted CSF can provide helpful information on antibiotics considered for the treatment of bacterial infections residing in CSF.

References

  1. Meng X, Pei Y, Nightingale C, Quintiliani R: Determination of the in vivo post-antibiotic effects of ciprofloxacin and rifampicin. J Antimicrob Chemother. 1995, 36: 987-996. 10.1093/jac/36.6.987.

    Article  CAS  PubMed  Google Scholar 

  2. Zhanel G, Karlowsky J, Davidson R, Hoban D: Effect of pooled human cerebrospinal fluid on the postantibiotic effects of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli. Antimicrob Agents Chemother. 1992, 36: 1136-1139.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Cunniffe J, Whitby-Strevens S, Wilcox M: Effect of pH changes in cerebrospinal fluid specimens on bacterial survival and antigen test results. J Clin Pathol. 1996, 49: 249-253. 10.1136/jcp.49.3.249.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert Sauermann.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Schwameis, R., Sauermann, R., Fille, M. et al. Antimicrobial activity of cefepime and rifampicin in cerebrospinal fluid in vitro. BMC Pharmacol 8 (Suppl 1), A56 (2008). https://doi.org/10.1186/1471-2210-8-S1-A56

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/1471-2210-8-S1-A56

Keywords

  • Antimicrobial Activity
  • Cerebrospinal Fluid
  • Drug Concentration
  • Staphylococcus Aureus
  • Rifampicin